Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033707 · ClinicalTrials.gov registry record · Phase 1
Effects of Hallucinogens and Other Drugs on Mood and Performance
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT02033707: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT02033707 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02033707, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This non-treatment study will investigate the effects on mood and performance caused by hallucinogens and other psychoactive compounds.
Interventions
- DRUG Hallucinogens and psychoactive substances
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02033707
The ClinicalTrials.gov registry entry for NCT02033707 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hallucinogens and psychoactive substances is the first listed.
NCT02033707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02033707 about?
NCT02033707 is a clinical study titled "Effects of Hallucinogens and Other Drugs on Mood and Performance". This non-treatment study will investigate the effects on mood and performance caused by hallucinogens and other psychoactive compounds.
What is the current status of trial NCT02033707?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2014-04. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02033707?
The interventions under investigation include: Hallucinogens and psychoactive substances (DRUG).
Who is sponsoring clinical trial NCT02033707?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.